Vaccaro, Olga <br/><br/>
The TOSCA.IT trial: a study designed to evaluate the effect of pioglitazone versus sulfonylureas on cardiovascular disease in type 2 diabetes.  [electronic resource] 

 -  Diabetes care  Dec 2012 
 - e82 p.  digital 
<br/><br/> Publication Type: Letter; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1935-5548 
<br/><br/><label>Standard No.: </label>10.2337/dc12-0954  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Cardiovascular Diseases--drug therapy<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Female<br/>Humans<br/>Hypoglycemic Agents--therapeutic use<br/>Male<br/>Middle Aged<br/>Pioglitazone<br/>Quality of Life<br/>Sulfonylurea Compounds--therapeutic use<br/>Thiazolidinediones--therapeutic use<br/>Treatment Outcome